Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.70 |
| ▸ | TP53 | P04637 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | THRB | P10828 | 3/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1718125 | 0.84 | MAPT (0.80) | MAPTTP53KDM4ELMNATHRB | |
| SCHEMBL1718055 | 0.84 | MAPT (0.76) | MAPTTP53KDM4ELMNATHRB | |
| SCHEMBL1718469 | 0.84 | MAPT (0.68) | MAPTTP53KDM4ELMNATHRB | |
| SCHEMBL1718388 | 0.84 | THRB (0.73) | MAPTTP53LMNATHRBSMN1; SMN2 | |
| SCHEMBL1718821 | 0.83 | MAPT (0.84) | MAPTTP53KDM4ELMNATHRB | |
| SCHEMBL1718665 | 0.83 | MAPT (0.75) | MAPTTP53KDM4ELMNATHRB | |
| SCHEMBL1718784 | 0.83 | MAPT (0.80) | MAPTTP53KDM4ELMNATHRB | |
| SCHEMBL1719663 | 0.83 | MAPT (0.75) | MAPTTP53KDM4ELMNATHRB | |
| SCHEMBL1719243 | 0.82 | MAPT (0.83) | MAPTTP53KDM4ELMNATHRB | |
| SCHEMBL1718438 | 0.82 | MAPT (0.74) | MAPTTP53KDM4ELMNATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1506196-B1 | PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS | ICAGEN INC (US) | 2012-01-18 | — | — | EP | claimed |
| EP-1506196-B1 | PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS | ICAGEN INC (US) | 2012-01-18 | — | — | EP | disclosed |